A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

被引:2
作者
Zhang, Hai-Feng [1 ,2 ]
Delaidelli, Alberto [1 ,2 ]
Javed, Sumreen [3 ]
Turgu, Busra [1 ,2 ]
Morrison, Taylor [2 ]
Hughes, Christopher S. [1 ,2 ]
Yang, Xiaqiu [2 ]
Pachva, Manideep [1 ,2 ]
Lizardo, Michael M. [1 ,2 ]
Singh, Gurdeep [2 ]
Hoffmann, Jennifer [4 ,5 ]
Huang, Yue Zhou [2 ]
Patel, Khushbu [4 ,5 ,6 ]
Shraim, Rawan [4 ,5 ,7 ]
Kung, Sonia H. Y. [8 ]
Morin, Gregg B. [9 ,10 ]
Aparicio, Samuel [1 ,2 ]
Martinez, Daniel [4 ,5 ,6 ]
Maris, John M. [4 ,5 ,6 ]
Bosse, Kristopher R. [4 ,5 ,6 ]
Williams, Karla C. [3 ]
Sorensen, Poul H. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada
[2] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[7] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA
[8] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[9] Canadas Michael Smith Genome Sci Ctr, Vancouver V5Z 4S6, BC, Canada
[10] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T1Z4, Canada
基金
加拿大健康研究院;
关键词
MIGRATION INHIBITORY FACTOR; DEAD BOX GENE; PLEIOTROPIC ROLE; GREB1; MEDULLOBLASTOMA; COAMPLIFICATION; EXPRESSION; MORPHOLOGY; REGULATOR; PROTEINS;
D O I
10.1126/sciadv.adg6693
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to MNA(+) NB remains poorly understood. Here, we identify that GREB1, a transcription factor encoding gene neighboring the MYCN locus, is frequently coexpressed with MYCN and promotes cell survival in MNA(+) NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B (MYO1B) as being highly expressed in MNA(+) NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in MNA(+) NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in MNA(+) NB and independently of MYCN.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development
    Liu, Yiyun
    Hamid, Naima
    Manzoor, Rakia
    Zhang, Bao-Fu
    Liao, Yan-Ling
    Pei, De-Sheng
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 912
  • [42] LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis
    Zhu, Shizhen
    Zhang, Xiaoling
    Weichert-Leahey, Nina
    Dong, Zhiwei
    Zhang, Cheng
    Lopez, Gonzalo
    Tao, Ting
    He, Shuning
    Wood, Andrew C.
    Oldridge, Derek
    Ung, Choong Yong
    van Ree, Janine H.
    Khan, Amish
    Salazar, Brittany M.
    da Rocha, Edroaldo Lummertz
    Zimmerman, Mark W.
    Guo, Feng
    Cao, Hong
    Hou, Xiaonan
    Weroha, S. John
    Perez-Atayde, Antonio R.
    Neuberg, Donna S.
    Meves, Alexander
    McNiven, Mark A.
    van Deursen, Jan M.
    Li, Hu
    Maris, John M.
    Look, A. Thomas
    CANCER CELL, 2017, 32 (03) : 310 - +
  • [43] MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma
    Jansen, Robin W.
    de Bloeme, Christiaan M.
    Cardoen, Liesbeth
    Goricke, Sophia
    van Elst, Sabien
    Jessen, Jaime Lyn
    Ramasubramanian, Aparna
    Skalet, Alison H.
    Miller, Audra K.
    Maeder, Philippe
    Uner, Ogul E.
    Hubbard, G. Baker
    Grossniklaus, Hans
    Boldt, H. Culver
    Nichols, Kim E.
    Brennan, Rachel C.
    Sen, Saugata
    Sirin, Selma
    Brisse, Herve J.
    Galluzzi, Paolo
    Dommering, Charlotte J.
    Castelijns, Jonas A.
    van der Valk, Paul
    Boellaard, Ronald
    Dorsman, Josephine
    Moll, Annette C.
    de Jong, Marcus C.
    de Graaf, Pim
    RADIOLOGY, 2023, 307 (05)
  • [44] 2p24 Gain Region Harboring MYCN Gene Compared with MYCN Amplified and Nonamplified Neuroblastoma Biological and Clinical Characteristics
    Jeison, Marta
    Ash, Shifra
    Halevy-Berko, Gili
    Mardoukh, Jacques
    Luria, Drorit
    Avigad, Smadar
    Feinberg-Gorenshtein, Galina
    Goshen, Yacov
    Hertzel, Gabriel
    Kapelushnik, Joseph
    Ben Barak, Aye Let
    Attias, Dina
    Steinberg, Ran
    Stein, Jerry
    Stark, Batia
    Yaniv, Isaac
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (06) : 2616 - 2625
  • [45] miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
    Swarbrick, Alexander
    Woods, Susan L.
    Shaw, Alexander
    Balakrishnan, Asha
    Phua, Yuwei
    Nguyen, Akira
    Chanthery, Yvan
    Lim, Lionel
    Ashton, Lesley J.
    Judson, Robert L.
    Huskey, Noelle
    Blelloch, Robert
    Haber, Michelle
    Norris, Murray D.
    Lengyel, Peter
    Hackett, Christopher S.
    Preiss, Thomas
    Chetcuti, Albert
    Sullivan, Christopher S.
    Marcusson, Eric G.
    Weiss, William
    L'Etoile, Noelle
    Goga, Andrei
    NATURE MEDICINE, 2010, 16 (10) : 1134 - U113
  • [46] Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism
    Mandriota, Stefano J.
    Valentijn, Linda J.
    Lesne, Laurence
    Betts, David R.
    Marino, Denis
    Boudal-Khoshbeen, Mary
    London, Wendy B.
    Rougemont, Anne-Laure
    Attiyeh, Edward F.
    Maris, John M.
    Hogarty, Michael D.
    Koster, Jan
    Molenaar, Jan J.
    Versteeg, Rogier
    Ansari, Marc
    Gumy-Pause, Fabienne
    ONCOTARGET, 2015, 6 (21) : 18558 - 18576
  • [47] Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration
    Duijkers, Floor A. M.
    Meijerink, Jules P. P.
    Pieters, Rob
    van Noesel, Max M.
    GENE, 2013, 521 (01) : 62 - 68
  • [48] CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth
    Huynh, Tony
    Murray, Jayne
    Flemming, Claudia L.
    Kamili, Alvin
    Hofmann, Ute
    Cheung, Leanna
    Roundhill, Elizabeth A.
    Yu, Denise M. T.
    Webber, Hannah T.
    Schwab, Matthias
    Henderson, Michelle J.
    Haber, Michelle
    Norris, Murray D.
    Fletcher, Jamie, I
    BIOCHEMICAL PHARMACOLOGY, 2020, 172
  • [49] Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma
    Zugbi, Santiago
    Ganiewich, Daiana
    Bhattacharyya, Arpita
    Aschero, Rosario
    Ottaviani, Daniela
    Sampor, Claudia
    Cafferata, Eduardo G.
    Mena, Marcela
    Sgroi, Mariana
    Winter, Ursula
    Lamas, Gabriela
    Sunol, Mariona
    Daroqui, Manuel
    Baialardo, Edgardo
    Salas, Beatriz
    Das, Anirban
    Fandino, Adriana
    Francis, Jasmine H.
    Lubieniecki, Fabiana
    Lavarino, Cinzia
    Garippa, Ralph
    Podhjacer, Osvaldo L.
    Abramson, David H.
    Radvanyi, Francois
    Chantada, Guillermo
    Llera, Andrea S.
    Schaiquevich, Paula
    CANCERS, 2020, 12 (09) : 1 - 20
  • [50] A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines
    Sugimoto, Tohru
    Gotoh, Takahiro
    Yagyu, Sigeki
    Kuroda, Hiroshi
    Iehara, Tomoko
    Hosoi, Hajime
    Ohta, Sigeru
    Ohira, Miki
    Nakagawara, Akira
    CANCER LETTERS, 2013, 331 (01) : 115 - 121